At this year's Digital Health Day, we will highlight different perspectives on innovation in the healthcare ecosystem: ...

Neural Concept and Fintech startup GenTwo have opened offices in New York and London, setting a firm foothold in the heart of engineering and finance powerhouses, respectively. In addition, new ...

Menhir Photonics, a Swiss-based ultrafast laser solutions provider, has secured a seven-figure growth loan to fuel its ambitious expansion plans, including the construction of its new production ...

Programs organized by global organizations including the United Nations, Bosch and Swiss Re have acknowledged the achievements of a Swiss startups, awarding them cash prizes and support to boost their ...

Since 2016, Synple Chem has been developing automated laboratory equipment for chemistry research, today serving customers worldwide including Novartis, AstraZeneca, Lilly and Bayer. The ETH spinoff ...

Summa Equity, a Stockholm-based private equity firm has acquired NetGuardians, a Swiss-based pioneer in AI-driven fraud prevention and anti-money laundering solutions. This opens an opportunity for a ...

Switzerland has come out on top in three new studies. Both the World Intellectual Property Organisation (WIPO) and the consulting firm Roland Berger have crowned Switzerland the world champion of ...

Selma Finance hat erneut eine Crowdinvesting-Kampagne laciert. Nach 25 Minuten wurde bereits die 500'000 Euro-Marke geknackt und über Nacht hat sich die Summe nochmals mehr als verdoppelt. Mit dem ...

Recently awarded the prestigious Prix à l'Innovation 2024 by the Prix de l'Economie de Genève, Alohi is a fast-growing scale-up providing secure and innovative communication solutions for businesses.

Mabylon AG is a Schlieren-based biotechnology company at the forefront of human-derived antibody research, with a primary focus on allergies, neurological and inflammatory disorders. The company has ...

Tech4Eva 2024 start-ups - promising women's healthcare companies - will pitch live to the investor audience. Investors will have the opportunity to engage in a Q&A session with the Founders and ...

Translation-X, a spin-off from Biozentrum University of Basel, is exploring selective mRNA translation as a therapeutic avenue for autism spectrum disorders. The company has won a CHF 150,000 Venture ...